Common Names
Geographic Range: India (Rajasthan, Madhya Pradesh, Gujarat, Bihar), North Africa, Arabian Peninsula
Known Contraindications
1
Compounds
3
Traditions
3
Treatments
4
Conditions
CC1(C)CCC2(C)CC[C@]3(C)[C@@H](CC(=O)[C@@H]4[C@@]5(C)CC[C@@H](OC(C)=O)C(C)(C)[C@@H]5CC[C@@]34C)[C@]2(C)C1CYP Interaction Profile
| Enzyme | Interaction |
|---|---|
| CYP1A2 | no significant interaction |
| CYP2C9 | weak inhibitor |
| CYP2D6 | no significant interaction |
| CYP3A4 | moderate inhibitor |
| CYP2C19 | weak inhibitor |
| clinical_note | Moderate CYP3A4 inhibition — caution with statins, calcium channel blockers |